To investigate the effects of IgG-BCR Fc glycans on B-cell function, we made use of the Burkitt lymphoma B-cell line (Ramos) and knocked out the N(297)-linked glycosylation site on mIgG. This evidence concerns the gene BCR and Burkitt lymphoma.